American Oncology Network, Inc.
AONC
$6.01
$0.010.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 51.62% | 40.12% | 38.51% | 19.79% | 7.60% |
| Total Other Revenue | 36.05% | 16.91% | -31.41% | 44.59% | 39.39% |
| Total Revenue | 51.42% | 39.84% | 37.79% | 19.95% | 7.92% |
| Cost of Revenue | 185.79% | 39.52% | 38.84% | 27.43% | 15.48% |
| Gross Profit | 673.60% | 43.77% | 24.72% | -62.73% | -61.55% |
| SG&A Expenses | 132.05% | 37.85% | 53.62% | 19.23% | 32.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.50% | 39.39% | 39.96% | 26.79% | 16.81% |
| Operating Income | 143.32% | 746.70% | -2,016.71% | -1,376.08% | -401.74% |
| Income Before Tax | 110.47% | 90.47% | -332.10% | -1,384.99% | -- |
| Income Tax Expenses | -204.35% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 110.76% | 90.69% | -310.30% | -1,579.74% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -105.85% | -98.26% | -- | -- | -- |
| Net Income | 135.09% | 40.35% | 143.67% | -427.66% | -- |
| EBIT | 143.32% | 746.70% | -2,016.71% | -1,376.08% | -401.74% |
| EBITDA | 166.36% | 92.08% | -382.84% | -544.26% | -320.69% |
| EPS Basic | 99.61% | 68.94% | 8.72% | -- | -- |
| Normalized Basic EPS | -89.93% | -102.53% | 219.18% | -- | -- |
| EPS Diluted | 99.61% | 68.85% | -199.91% | -- | -- |
| Normalized Diluted EPS | -89.93% | -102.53% | 136.55% | -- | -- |
| Average Basic Shares Outstanding | 237.52% | 100.54% | -13.94% | -- | -- |
| Average Diluted Shares Outstanding | 237.52% | 100.54% | 180.56% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |